What is a stock summary page? Click here for an overview.
Business Description
GH Research PLC
NAICS : 541714
SIC : 2834
ISIN : IE000GID8VI0
Description
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 239.3 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -52.3 | |||||
| 3-Year EPS without NRI Growth Rate | -35.6 | |||||
| 3-Year FCF Growth Rate | -32.2 | |||||
| 3-Year Book Growth Rate | -13.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -25.77 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.8 | |||||
| 9-Day RSI | 39.01 | |||||
| 14-Day RSI | 43.83 | |||||
| 3-1 Month Momentum % | 44.71 | |||||
| 6-1 Month Momentum % | 58.03 | |||||
| 12-1 Month Momentum % | -8.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.23 | |||||
| Quick Ratio | 17.23 | |||||
| Cash Ratio | 16.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -19.56 | |||||
| ROA % | -18.75 | |||||
| ROIC % | -93.26 | |||||
| 3-Year ROIIC % | -101.77 | |||||
| ROC (Joel Greenblatt) % | -4260.72 | |||||
| ROCE % | -19.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.13 | |||||
| Price-to-Tangible-Book | 3.13 | |||||
| EV-to-EBIT | -13.39 | |||||
| EV-to-EBITDA | -13.5 | |||||
| EV-to-Forward-EBITDA | -9.01 | |||||
| EV-to-FCF | -12.25 | |||||
| Price-to-Net-Current-Asset-Value | 3.86 | |||||
| Price-to-Net-Cash | 4 | |||||
| Earnings Yield (Greenblatt) % | -7.47 | |||||
| FCF Yield % | -6.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GHRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
GH Research PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.75 | ||
| Beta | 0.83 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.11 | ||
| Volatility % | 83.38 | ||
| 14-Day RSI | 43.83 | ||
| 14-Day ATR ($) | 0.977217 | ||
| 20-Day SMA ($) | 11.348 | ||
| 12-1 Month Momentum % | -8.57 | ||
| 52-Week Range ($) | 6 - 20.5 | ||
| Shares Outstanding (Mil) | 62.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GH Research PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GH Research PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GH Research PLC Frequently Asked Questions
What is GH Research PLC(GHRS)'s stock price today?
The current price of GHRS is $10.76. The 52 week high of GHRS is $20.50 and 52 week low is $6.00.
When is next earnings date of GH Research PLC(GHRS)?
The next earnings date of GH Research PLC(GHRS) is 2025-05-02 Est..
Does GH Research PLC(GHRS) pay dividends? If so, how much?
GH Research PLC(GHRS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers